Transparency Market Research has announced the publication of a new report, titled “Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”. The report offers a comprehensive overview of the global biological drugs market. The valuable insight shared by the expert industry analysts suggests that this market is expected to grow at a CAGR of 10.10% in the coming years. The report analyzes the causes responsible for this growth rate by studying the market drivers and opportunities. Furthermore, it also uses credible market measurement tools to make a fair assessment of forces governing this market.

According to the research report, the global biological drugs market was valued at US$161 bn in 2014 and is estimated to reach US$287.1 bn by 2020. This impressive growth rate is attributable to the growing incidence of chronic diseases and their diagnoses. Biological drugs have played a vital role in treating blood-related diseases, cancer, auto-immune diseases, and various medical disorders.In recent decades, the biological drugs market has picked up pace due to the rising incidence of chronic diseases and increasing availability of advanced diagnostics. The market is also gaining an impetus due to the increasing geriatric population and government initiatives to manage national healthcare. The increasing research activities in the field of biomedical science, which is funded by both public and private organizations, is also leading to the growth of the global biological drugs market.

Despite the strong undercurrent of market drivers, the global biological drugs market is facing tough competition from the alternative of injectable biological medicines. The other restraints on the global biological drugs market are the chances of patent expiry of various biological drugs and high cost of biological drugs. The analysts have observed that anti-vascular endothelial growth factor (VEGF) therapy in the biopharmaceutical industry and genetically modified organisms (GMOs) will accelerate in the near future.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1694

The global biological drugs market is segmented on the basis of into therapeutic proteins, monoclonal antibodies (mAb), and vaccines, and by geography. The therapeutic proteins used in the biological drug market are Betaseron, Epogen, Aranesp, Neupogen, Lantus, Victoza, Avonex, NovoLog, Enbrel, Humalog, Rebif, Eylea, Levemir, and Neulasta. The list of monoclonal antibodies in the biological drugs market includes Remicade, Herceptin, Humira, Lucentis, Rituxan, and Avastin. The vaccines available in the global biological drugs market are Prenvar 13, Fluzone, Gardasil, Cervarix, and Varivax. Geographically, this market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

The biological drugs market is expected to grow in the aforementioned regions due to the huge demand for drugs to treat autoimmune diseases, cancer and related conditions, blood diseases, diabetes, and cardiovascular diseases.Some of the important players studied in this market research report are Unilife Corporation, Retractable Technologies, Inc., Smiths Medicals, Becton, Dickinson & Company, Smiths Medical, and Terumo Corporation. The chapter on company profiles discusses a company overview, financial status, marketing and advertising strategies, product positioning, branding, research and development activities, and investment plans for the future.

The global biological drug market is segmented in the following ways:

Segmentation by therapeutic protein:
•Levemir
•Neulasta
•Eylea
•Rebif
•NovoLog
•Enbrel
•Avonex
•Neupogen
•Humalog
•Victoza
•Lantus
•Epogen
•Aranesp
•Betaseron

Segmentation by monoclonal antibody (mAb):
•Avastin
•Rituxan
•Lucentis
•Humira
•Herceptin
•Remicade

Segmentation by vaccine:
•Gardasil
•Prenvar 13
•Fluzone
•Cervarix
•Varivax

Major geographies analyzed under this research report are:
•Europe
•North America
•Asia-Pacific
•Rest of the World

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:

Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/